98 related articles for article (PubMed ID: 19942441)
21. Tumor-targeted bioconjugate based delivery of camptothecin: design, synthesis and in vitro evaluation.
Paranjpe PV; Chen Y; Kholodovych V; Welsh W; Stein S; Sinko PJ
J Control Release; 2004 Nov; 100(2):275-92. PubMed ID: 15544875
[TBL] [Abstract][Full Text] [Related]
22. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
Koo OM; Rubinstein I; Onyuksel H
Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
[TBL] [Abstract][Full Text] [Related]
23. Water-soluble poly-(L-glutamic acid)-Gly-camptothecin conjugates enhance camptothecin stability and efficacy in vivo.
Singer JW; Bhatt R; Tulinsky J; Buhler KR; Heasley E; Klein P; de Vries P
J Control Release; 2001 Jul; 74(1-3):243-7. PubMed ID: 11489501
[TBL] [Abstract][Full Text] [Related]
24. Redox-sensitive dimeric camptothecin phosphatidylcholines-based liposomes for improved anticancer efficacy.
He W; Du Y; Zhou W; Yao C; Li X
Nanomedicine (Lond); 2019 Dec; 14(23):3057-3074. PubMed ID: 31696756
[No Abstract] [Full Text] [Related]
25. Molecularly precise dendrimer-drug conjugates with tunable drug release for cancer therapy.
Zhou Z; Ma X; Murphy CJ; Jin E; Sun Q; Shen Y; Van Kirk EA; Murdoch WJ
Angew Chem Int Ed Engl; 2014 Oct; 53(41):10949-55. PubMed ID: 25155439
[TBL] [Abstract][Full Text] [Related]
26. Water soluble 20(S)-glycinate esters of 10,11-methylenedioxycamptothecins are highly active against human breast cancer xenografts.
Wadkins RM; Potter PM; Vladu B; Marty J; Mangold G; Weitman S; Manikumar G; Wani MC; Wall ME; Von Hoff DD
Cancer Res; 1999 Jul; 59(14):3424-8. PubMed ID: 10416605
[TBL] [Abstract][Full Text] [Related]
27. Folate-decorated and reduction-sensitive micelles assembled from amphiphilic polymer-camptothecin conjugates for intracellular drug delivery.
Liu C; Yuan J; Luo X; Chen M; Chen Z; Zhao Y; Li X
Mol Pharm; 2014 Nov; 11(11):4258-69. PubMed ID: 25238329
[TBL] [Abstract][Full Text] [Related]
28. Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory model.
Sapra P; Zhao H; Mehlig M; Malaby J; Kraft P; Longley C; Greenberger LM; Horak ID
Clin Cancer Res; 2008 Mar; 14(6):1888-96. PubMed ID: 18347192
[TBL] [Abstract][Full Text] [Related]
29. In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin.
Watanabe M; Kawano K; Toma K; Hattori Y; Maitani Y
J Control Release; 2008 May; 127(3):231-8. PubMed ID: 18384903
[TBL] [Abstract][Full Text] [Related]
30. Potent topoisomerase I inhibition by novel silatecans eliminates glioma proliferation in vitro and in vivo.
Pollack IF; Erff M; Bom D; Burke TG; Strode JT; Curran DP
Cancer Res; 1999 Oct; 59(19):4898-905. PubMed ID: 10519402
[TBL] [Abstract][Full Text] [Related]
31. Irinotecan delivery by microbubble-assisted ultrasound: in vitro validation and a pilot preclinical study.
Escoffre JM; Novell A; Serrière S; Lecomte T; Bouakaz A
Mol Pharm; 2013 Jul; 10(7):2667-75. PubMed ID: 23675982
[TBL] [Abstract][Full Text] [Related]
32. [Irinotecan hydrochloride (CPT-11)].
Furue H
Gan To Kagaku Ryoho; 1994 Apr; 21(5):709-17. PubMed ID: 8154899
[TBL] [Abstract][Full Text] [Related]
33. Biologically active camptothecin derivatives for incorporation into liposome bilayers and lipid emulsions.
Lundberg BB
Anticancer Drug Des; 1998 Jul; 13(5):453-61. PubMed ID: 9702210
[TBL] [Abstract][Full Text] [Related]
34. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo.
Yu D; Peng P; Dharap SS; Wang Y; Mehlig M; Chandna P; Zhao H; Filpula D; Yang K; Borowski V; Borchard G; Zhang Z; Minko T
J Control Release; 2005 Dec; 110(1):90-102. PubMed ID: 16271793
[TBL] [Abstract][Full Text] [Related]
35. Probing a dipeptide-based supramolecular assembly as an efficient camptothecin delivering carrier for cancer therapy: computational simulations and experimental validations.
Sun M; Zhang X; Gao Z; Liu T; Luo C; Zhao Y; Liu Y; He Z; Wang J; Sun J
Nanoscale; 2019 Feb; 11(9):3864-3876. PubMed ID: 30758022
[TBL] [Abstract][Full Text] [Related]
36. Preparation of camptothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stability.
Watanabe M; Kawano K; Yokoyama M; Opanasopit P; Okano T; Maitani Y
Int J Pharm; 2006 Feb; 308(1-2):183-9. PubMed ID: 16324807
[TBL] [Abstract][Full Text] [Related]
37. Targeted tumor theranostics using folate-conjugated and camptothecin-loaded acoustic nanodroplets in a mouse xenograft model.
Chen WT; Kang ST; Lin JL; Wang CH; Chen RC; Yeh CK
Biomaterials; 2015; 53():699-708. PubMed ID: 25890765
[TBL] [Abstract][Full Text] [Related]
38. Potent and broad antitumor effects of DX-8951f, a water-soluble camptothecin derivative, against various human tumors xenografted in nude mice.
Kumazawa E; Jimbo T; Ochi Y; Tohgo A
Cancer Chemother Pharmacol; 1998; 42(3):210-20. PubMed ID: 9685056
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation (in vitro and in vivo) of cyclic arginine-glycine-aspartate (RGD) peptidomimetic-paclitaxel conjugates targeting integrin αVβ3.
Colombo R; Mingozzi M; Belvisi L; Arosio D; Piarulli U; Carenini N; Perego P; Zaffaroni N; De Cesare M; Castiglioni V; Scanziani E; Gennari C
J Med Chem; 2012 Dec; 55(23):10460-74. PubMed ID: 23140358
[TBL] [Abstract][Full Text] [Related]
40. [Synthesis of polyrotaxane-camptothecin conjugates and evaluation of its anti-tumor effect].
Lai CL; Lai L; Zhao JB; Chen JH
Yao Xue Xue Bao; 2010 Jul; 45(7):920-5. PubMed ID: 20931793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
